These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1376809)

  • 1. Effect of E-4031, a class III antiarrhythmic agent, on experimental infarct size in a canine model of myocardial ischemia-reperfusion injury.
    Holahan MA; Stranieri MT; Stabilito II; Lynch JJ
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):892-8. PubMed ID: 1376809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.
    Pelc LR; Farber NE; Warltier DC; Gross GJ
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):586-93. PubMed ID: 2470996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
    Hennan JK; Swillo RE; Morgan GA; Keith JC; Schaub RG; Smith RP; Feldman HS; Haugan K; Kantrowitz J; Wang PJ; Abu-Qare A; Butera J; Larsen BD; Crandall DL
    J Pharmacol Exp Ther; 2006 Apr; 317(1):236-43. PubMed ID: 16344331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Auchampach JA; Pieper GM; Cavero I; Gross GJ
    Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
    J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Rydén L
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):339-45. PubMed ID: 12198319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
    Gumina RJ; Daemmgen J; Gross GJ
    Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
    Chi LG; Tamura Y; Hoff PT; Macha M; Gallagher KP; Schork MA; Lucchesi BR
    Circ Res; 1989 Apr; 64(4):665-75. PubMed ID: 2702730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of activation of ATP-dependent potassium channels with (-)-pinacidil and (-)-3-pyridyl pinacidil on infarct size in a canine model of ischemia-reperfusion injury.
    Smallwood JK; Schelm JA; Bemis KG; Simpson PJ
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):731-43. PubMed ID: 7506326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
    McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
    J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coronary reocclusion after initial reperfusion on ventricular function and infarct size.
    Lim MJ; Gallagher MA; Ziadeh M; Buda AJ
    J Am Coll Cardiol; 1991 Sep; 18(3):879-85. PubMed ID: 1869753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
    Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
    J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ethanol on myocardial infarct size in a canine model of coronary artery occlusion-reperfusion.
    Itoya M; Morrison JD; Downey HF
    Mol Cell Biochem; 1998 Sep; 186(1-2):35-41. PubMed ID: 9774183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion.
    Ghaleh B; Thireau J; Cazorla O; Soleti R; Scheuermann V; Bizé A; Sambin L; Roubille F; Andriantsitohaina R; Martinez MC; Lacampagne A
    Theranostics; 2020; 10(9):4006-4016. PubMed ID: 32226535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
    Bush LR; Romson JL; Ash JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(2):285-96. PubMed ID: 6175813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].
    Tamura Y; Saito S; Hatano M; Lucchesi BR
    Kokyu To Junkan; 1989 Feb; 37(2):201-8. PubMed ID: 2727408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
    Fiedler VB; Perzborn E; Seuter F
    Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.